About   Help   FAQ
Phenotypes Associated with This Genotype
Genotype
MGI:6505535
Allelic
Composition
Med19tm1c(EUCOMM)Wtsi/Med19tm1c(EUCOMM)Wtsi
Tg(Adipoq-cre)1Evdr/0
Genetic
Background
involves: C57BL/6J * C57BL/6N * FVB/NJ
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Med19tm1c(EUCOMM)Wtsi mutation (0 available); any Med19 mutation (13 available)
Tg(Adipoq-cre)1Evdr mutation (3 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
growth/size/body
• reduced fat mass in both sexes at 12 weeks of age, as revealed by body composition analysis (EchoMRI)
• slightly increased lean mass in both sexes at 12 weeks of age, as revealed by EchoMRI
• increased body weight in both sexes at 9 and 12 weeks of age, but not at 3 or 6 weeks of age
• however, food intake is not significantly altered
• enlarged liver at 12 weeks of age
• markedly increased liver weight at 12 weeks of age

adipose tissue
• reduced fat mass in both sexes at 12 weeks of age, as revealed by body composition analysis (EchoMRI)
• brown adipose tissue (BAT) contains many white-adipocyte-like unilocular cells, indicating whitening of brown fat
• however, no change in brown adipose tissue (BAT) mass at 3 or 12 weeks of age
• severely reduced gonadal white fat depot (gWAT) weight in males as early as 3 weeks of age
• severely reduced inguinal white fat depot (iWAT) weight in males as early as 3 weeks of age
• reduction in mesenteric WAT (mWAT) weight at 12 weeks of age
• reduction in retroperitoneal WAT (rWAT) weight at 12 weeks of age
• interscapular BAT is much paler at 12 weeks of age, resembling WAT
• small amount of residual WAT appears unhealthy with sparse, irregularly sized adipocytes among a fibrous extracellular matrix
• reduction in anterior subcutaneous WAT (asWAT) weight at 12 weeks of age
• sparse white adipocytes
• irregularly sized white adipocytes
• dramatic reduction in white adipose tissue mass at 12 weeks of age
• however, no change in brown adipose tissue (BAT) mass at 3 or 12 weeks of age
• mRNA expression of BAT genes, including Ucp1, is reduced
• gene expression analysis of gWAT and iWAT revealed reduced mRNA levels of the adipocyte genes aP2, C/EBPalpha, and PPARgamma; mRNA expression of C/EBPbeta and KLF5 is either unchanged or elevated

homeostasis/metabolism
• both sexes are hyperglycemic
• markedly increased fasting serum insulin levels
• both sexes are glucose intolerant
• impaired response to insulin in insulin tolerance test
• 4-fold increase in liver triglyceride content

liver/biliary system
• enlarged liver at 12 weeks of age
• markedly increased liver weight at 12 weeks of age
• 4-fold increase in liver triglyceride content
• massive accumulation of lipid droplets in liver at 12 weeks of age
• pale liver at 12 weeks of age
• impaired hepatic insulin signaling, as assessed by phosphorylation of Akt in response to insulin

integument
• reduction in anterior subcutaneous WAT (asWAT) weight at 12 weeks of age


Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
01/06/2026
MGI 6.24
The Jackson Laboratory